Optimizing Value-Based Drug Pricing in Japan wi...

By João L. Carapinha

April 24, 2025

The article reviews MARIE, a qualitative multiple-criteria value-based drug pricing (VBP) framework designed for the Japanese drug pricing system to address price adjustments for drugs with updated clinical status. By applying MARIE to 32 drugs, a...
Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...
Capivasertib Cost-Effectiveness in Advanced Breast Cancer
Reserve Antibiotics Benefits: G-BA Designates Meropenem/Vaborbactam as Critic...
NICE Grants Conditional Robotic Surgery Approval to Enhance Patient Care and ...
Cost-Effective HIV PrEP: CAB-LA Transforms Prevention
Advancing Early Childhood Health: PureHealth’s Partnership with Abu Dha...
Toripalimab Evidence Journey in Cancer Care
NICE Breakthrough: Record Positive Recommendations for Blood Cancer Treatment...
Approval of Pembrolizumab Enfortumab Therapy: Insights on Efficacy, Costs, an...
Cancer Control Month 2025: Key Takeaways from President Trump’s National Call...
Oral Cancer in East Africa: The Need for Early Detection